CN Patent

CN103664756A — 吡仑帕奈新晶型a及其制备方法

Assigned to Crystal Pharmatech Co Ltd · Expires 2014-03-26 · 12y expired

What this patent protects

本发明涉及一种命名为晶型A的吡仑帕奈的新晶型及其制备方法。所述晶型A，其特征在于X射线粉末衍射图在2theta值为7.4°±0.2°、9.6°±0.2°、19.2°±0.2°、17.4°±0.2°、15.2°±0.2°、8.8°±0.2°、12.0°±0.2°、22.9°±0.2°、14.2°±0.2°处具有特征峰。

USPTO Abstract

本发明涉及一种命名为晶型A的吡仑帕奈的新晶型及其制备方法。所述晶型A，其特征在于X射线粉末衍射图在2theta值为7.4°±0.2°、9.6°±0.2°、19.2°±0.2°、17.4°±0.2°、15.2°±0.2°、8.8°±0.2°、12.0°±0.2°、22.9°±0.2°、14.2°±0.2°处具有特征峰。

Drugs covered by this patent

Patent Metadata

Patent number
CN103664756A
Jurisdiction
CN
Classification
—
Expires
2014-03-26
Drug substance claim
No
Drug product claim
No
Assignee
Crystal Pharmatech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.